sintx technologies
-
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity
-
SINTX 2025 Highlights
As we look back at 2025, we’re thankful for the progress our team and partners helped drive this…
-
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
Milestone enables immediate production of SiN/PEEK custom devices
-
SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL APPLICATIONS
SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL APPLICATIONS
-
SINTX TECHNOLOGIES AND NED MEDICAL PARTNER TO ADVANCE CUTTING-EDGE CERAMIC MICROSPHERE MEDICAL DEVICES FOR CANCER TREATMENT
SINTX TECHNOLOGIES AND NED MEDICAL PARTNER TO ADVANCE CUTTING-EDGE CERAMIC MICROSPHERE MEDICAL DEVICES FOR CANCER TREATMENT
-
SINTX TECHNOLOGIES TO EXPLORE STRATEGIC OPPORTUNITIES
SINTX Technologies announced that its Board of Directors has initiated a process to explore potential strategic options for…
-
SINTX TECHNOLOGIES RECEIVES ADDITIONAL SBIR CONTRACT FOR 3D PRINTING TECHNOLOGY
SINTX TECHNOLOGIES RECEIVES ADDITIONAL SBIR CONTRACT FOR 3D PRINTING TECHNOLOGY
-
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS
SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy…
-
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE
SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop…
-
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED CRANIOMAXILLOFACIAL DEVICES
SINTX Technologies announced a Phase 1 grant of $300k awarded by the National Institutes of Health (NIH) to…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
